UM

Browse/Search Results:  1-8 of 8 Help

Selected(0)Clear Items/Page:    Sort:
Anti-TNFR2 Antibody-Conjugated PLGA Nanoparticles for Targeted Delivery of Adriamycin in Mouse Colon Cancer Journal article
Li, Ping, Yang, Yang, Wang, Yifei, Zheng, Jingbin, Chen, Fengyang, Jiang, Mengmeng, Chou, Chon Kit, Cong, Weihong, Li, Zongjin, Chen, Xin. Anti-TNFR2 Antibody-Conjugated PLGA Nanoparticles for Targeted Delivery of Adriamycin in Mouse Colon Cancer[J]. Research, 2024, 7, 0444.
Authors:  Li, Ping;  Yang, Yang;  Wang, Yifei;  Zheng, Jingbin;  Chen, Fengyang; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:8.5/8.7 | Submit date:2024/10/10
Therapeutic potential of TNFR2 agonists: a mechanistic perspective Journal article
Yibo Chen, Mengmeng Jiang, Xin Chen. Therapeutic potential of TNFR2 agonists: a mechanistic perspective[J]. Frontiers in Immunology, 2023, 14, 1209188.
Authors:  Yibo Chen;  Mengmeng Jiang;  Xin Chen
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:5.7/6.8 | Submit date:2023/08/31
Treg - Regulatory t Cell  Tnfr2 Agonism  Tnfr2  Tumor  Autoimmune Diseases  
TNFR2 expression predicts the responses to immune checkpoint inhibitor treatments Journal article
Ping Liao, Mengmeng Jiang, Md Sahidul Islam, Yiru Wang, XIN CHEN*. TNFR2 expression predicts the responses to immune checkpoint inhibitor treatments[J]. Frontiers in Immunology, 2023, 14, 1097090.
Authors:  Ping Liao;  Mengmeng Jiang;  Md Sahidul Islam;  Yiru Wang;  XIN CHEN*
Favorite | TC[WOS]:5 TC[Scopus]:5  IF:5.7/6.8 | Submit date:2023/08/31
Tnfr2  Immune Checkpoint Inhibitors  Tumor Microenvironment  Cd4 + Foxp3 + Regulatory t Cells  Exhausted Cd8 t Cells  Biomarker  
TNFR2 deficiency impairs the growth of mouse colon cancer Journal article
Li,Ping, Yang,Yang, Yang,Xinyu, Wang,Yifei, Chou,Chon Kit, Jiang,Mengmeng, Zheng,Jingbin, Chen,Fengyang, Chen,Xin*. TNFR2 deficiency impairs the growth of mouse colon cancer[J]. International Journal of Biological Sciences, 2023, 19(4), 1024-1035.
Authors:  Li,Ping;  Yang,Yang;  Yang,Xinyu;  Wang,Yifei;  Chou,Chon Kit; et al.
Favorite | TC[WOS]:8 TC[Scopus]:7  IF:8.2/8.3 | Submit date:2023/08/03
Tumor Necrosis Factor (Tnf)  Tumor Necrosis Factor Receptor Type Ii (Tnfr2)  Colon Cancer  Cancer Immunotherapy  
MiR-125b-5p modulates the function of regulatory T cells in tumor microenvironment by targeting TNFR2 Journal article
Jiang, Mengmeng, Yang, Yang, Niu, Liling, Li, Ping, Chen, Yibo, Liao, Ping, Wang, Yifei, Zheng, Jingbin, Chen, Fengyang, He, Huanhuan, Li, Hui, Chen, Xin*. MiR-125b-5p modulates the function of regulatory T cells in tumor microenvironment by targeting TNFR2[J]. Journal for ImmunoTherapy of Cancer, 2022, 10(11), e005241.
Authors:  Jiang, Mengmeng;  Yang, Yang;  Niu, Liling;  Li, Ping;  Chen, Yibo; et al.
Favorite | TC[WOS]:10 TC[Scopus]:9  IF:10.3/11.6 | Submit date:2022/12/01
Cd4-positive T-lymphocytes  Immunotherapy  Lymphocytes, Tumor-infiltrating  Tumor Microenvironment  
A TNFR2 antibody by countering immunosuppression cooperates with HMGN1 and R848 immune stimulants to inhibit murine colon cancer Journal article
Jiang, Mengmeng, Liu, Jia, Yang, De, Tross, Debra, Li, Ping, Chen, Fengyang, Alam, Md Masud, Faustman, Denise L., Oppenheim, Joost J., Chen, Xin. A TNFR2 antibody by countering immunosuppression cooperates with HMGN1 and R848 immune stimulants to inhibit murine colon cancer[J]. International Immunopharmacology, 2021, 101, 108345.
Authors:  Jiang, Mengmeng;  Liu, Jia;  Yang, De;  Tross, Debra;  Li, Ping; et al.
Favorite | TC[WOS]:22 TC[Scopus]:22  IF:4.8/5.0 | Submit date:2021/12/08
Antitumor  cd4+foxp3+ Regulatory t Cells (Tregs)  Hmgn1 And R848  Immunotherapy  Tnfr2  
Inhibition of two-pore channels in antigen-presenting cells promotes the expansion of TNFR2-expressing CD4+Foxp3+ regulatory T cells Journal article
He,Tianzhen, Yang,De, Li,Xiao Qing, Jiang,Mengmeng, Islam,Md Sahidul, Chen,Shaokui, Chen,Yibo, Yang,Yang, Chou,Chon Kit, Trivett,Anna L., Oppenheim,Joost J., Chen,Xin*. Inhibition of two-pore channels in antigen-presenting cells promotes the expansion of TNFR2-expressing CD4+Foxp3+ regulatory T cells[J]. Science Advances, 2020, 6(40), eaba6584.
Authors:  He,Tianzhen;  Yang,De;  Li,Xiao Qing;  Jiang,Mengmeng;  Islam,Md Sahidul; et al.
Favorite | TC[WOS]:14 TC[Scopus]:15  IF:11.7/13.7 | Submit date:2021/03/01
Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts Review article
2020
Authors:  Jin Wang;  Mengmeng Jiang;  Xin Chen;  Luis J. Montaner
Favorite | TC[WOS]:505 TC[Scopus]:549  IF:3.6/5.2 | Submit date:2021/03/01
Covid-19  Cytokine Storm  Immunotherapy  Leukocyte  Sars-cov-2